I don't think there was a halt in trading. Rather, it was simply a day with no volume. I think the market was taken it all in without making quick buy/sell decisions.
SalvaRx's shares nearly doubled. So, they're happy.
Like I said earlier, the PTGEF group is a proven winner. If they think this acquisition is a great deal to enhance shareholder value, I support this move.
News 
Market Data 
Discover 
